Stock Price Movement and Market Context
On 16 Mar 2026, TTK Healthcare Ltd. opened sharply lower with a gap down of -3.13%, continuing a two-day losing streak that has resulted in a cumulative decline of -4.44%. The stock touched an intraday low of Rs.815.05, establishing its lowest price point in the past year. This performance underperformed its sector by -0.7% on the day, reflecting a challenging trading environment for the diversified sector.
TTK Healthcare is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum. The broader market context is also unfavourable, with the Sensex falling by -238.52 points (-0.52%) to 74,177.27, itself nearing a 52-week low and down -8.75% over the past three weeks. The Sensex is trading below its 50-day moving average, which is itself below the 200-day moving average, indicating a bearish market trend.
Long-Term and Recent Performance Metrics
Over the last year, TTK Healthcare has delivered a total return of -24.94%, significantly underperforming the Sensex, which posted a modest gain of 0.41% over the same period. The stock’s 52-week high was Rs.1,402, highlighting the extent of the recent decline. This underperformance extends beyond the last year, with the stock lagging the BSE500 index over the past three years, one year, and three months.
Financially, the company has exhibited modest growth rates, with net sales increasing at an annualised rate of 6.99% and operating profit growing at 15.42% over the past five years. However, recent quarterly results have been flat, with non-operating income constituting 80.43% of profit before tax, indicating limited contribution from core business activities.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
Liquidity and Operational Ratios
TTK Healthcare’s cash and cash equivalents stood at Rs.600.89 crores in the half-year period, marking the lowest level recorded recently. The debtor turnover ratio also declined to 7.40 times, indicating slower collection cycles. These factors may contribute to tighter liquidity conditions for the company.
Despite its micro-cap status, domestic mutual funds hold a negligible stake of just 0.01%, suggesting limited institutional interest. Given that domestic mutual funds typically conduct thorough research, this minimal holding could reflect reservations about the company’s valuation or business prospects at current price levels.
Valuation and Profitability Indicators
TTK Healthcare maintains a low average debt-to-equity ratio of zero, indicating a debt-free capital structure. The company’s return on equity (ROE) stands at 6.5%, which, while positive, is modest relative to industry standards. The stock trades at a price-to-book value of 1.1, which is a premium compared to its peers’ historical averages.
Profit growth over the past year has been limited, with a 2.4% increase despite the stock’s negative return. The price/earnings to growth (PEG) ratio is elevated at 7, reflecting a valuation that may not be fully supported by earnings growth.
Technical Analysis Overview
Technical indicators present a predominantly bearish outlook for TTK Healthcare. The Moving Average Convergence Divergence (MACD) is bearish on both weekly and monthly charts. Bollinger Bands also signal bearish momentum across these timeframes. The daily moving averages confirm a bearish trend, while the Know Sure Thing (KST) indicator is bearish on weekly and monthly scales. Dow Theory assessments are mildly bearish, and On-Balance Volume (OBV) trends are mildly bearish as well. The Relative Strength Index (RSI) shows a mixed picture, with a bullish monthly reading but no clear weekly signal.
Holding TTK Healthcare Ltd. from Diversified? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Summary of Rating and Market Position
MarketsMOJO assigns TTK Healthcare a Mojo Score of 37.0 and a Mojo Grade of Sell, downgraded from Hold on 21 Jul 2025. The company is classified as a micro-cap within the diversified sector. This rating reflects the combination of subdued growth, valuation concerns, and technical weakness observed in the stock’s recent performance.
While the company’s low leverage and positive ROE provide some stability, the stock’s premium valuation relative to peers and limited profit growth have contributed to its current market position. The broader market’s bearish trend has also weighed on the stock, which has underperformed both its sector and the benchmark indices over multiple time horizons.
Conclusion
TTK Healthcare Ltd.’s fall to a 52-week low of Rs.815.05 highlights a period of sustained price weakness amid challenging market conditions and company-specific factors. The stock’s decline is underscored by underwhelming financial growth, limited institutional interest, and predominantly bearish technical indicators. Trading below all major moving averages and with a recent downgrade in rating, the stock remains under pressure in the current market environment.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
